部分
前药
化学
烷基化
反应性(心理学)
溶解度
溶剂
组合化学
产量(工程)
人类免疫缺陷病毒(HIV)
盐(化学)
水溶液
有机化学
催化作用
材料科学
生物化学
冶金
替代医学
家庭医学
病理
医学
作者
Richard J. Fox,Benjamin Cohen,Thomas E. La Cruz,James H. Simpson,Adam Freitag,Eric M. Saurer,Jonathan C. Tripp,Chien-Kuang Chen,Gregory L. Beutner,Victor W. Rosso,Elizabeth Borgeson,Andrew W. Glace,Martin D. Eastgate,Richard L. Schild,Jason T. Sweeney,David A. Conlon
标识
DOI:10.1021/acs.oprd.7b00135
摘要
The reaction optimization of an alkylation to enable the production of the penultimate intermediate of an HIV-attachment inhibitor candidate is described. To address the challenges associated with the reactivity and stability of di-tert-butyl (chloromethyl) phosphate (2), and the poor solubility and reactivity of the starting BMS-626529-Li salt (1), strategic selection of Et4NI and 325 mesh K2CO3 as additives, and wet CH3CN as solvent were required. An aqueous workup protocol was also developed to selectively remove an undesired N-6 alkylation isomer. The final processing conditions resulted in the isolation of the penultimate compound 3 in 70% yield with high purity.
科研通智能强力驱动
Strongly Powered by AbleSci AI